肿瘤新药:NKTR-214联合PD1药物,控制率高达百分之九十! ASCO是美国临床肿瘤学会的缩写,是具备影响力的肿瘤组织。每年ASCO都会发布很多抗癌新药,在今年的年会上,有一个备受期待的明星肿瘤新药,代号是NKTR-214。PD1药物,是较近几年抗癌领域大的发现,NKTR-214之所以能够成为一种明星肿瘤新药,它的作用就是提高PD1药物的效...
drug candidates (such as NKTR-214) is therefore highly uncertain and unpredictable and one or more research and development programs could fail; (vii) patents may not issue from our patent applications for our drug candidates including NKTR-214, patents that have issued may not b...
Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found onli...
This drug was only approved for metastatic melanoma and renal cell carcinoma. But for years and years, and even in the current era of immunotherapy, we understand that cytokines are overlapping immune stimulators differently from checkpoint inhibitors, differently from antiCTLA4, and differently ...